Keyphrases
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Advanced Fibrosis
100%
Intragastric Balloon
100%
Obese Patients
42%
Liver Stiffness
42%
Weight Loss
28%
Fibrosis-4 (FIB-4)
28%
Clinically Significant
14%
Randomized Controlled Trial
14%
Gastroesophageal Reflux
14%
Waist Circumference
14%
Metabolic Parameters
14%
Glycated Hemoglobin
14%
Blood Glucose
14%
Fibrosis Regression
14%
Circumference Reduction
14%
Liver Parameters
14%
Endoscopic Placement
14%
6-month Follow-up
14%
Fluid-filled
14%
Orbera
14%
Effective Therapy
14%
Controlled Attenuation Parameter
14%
Significant Fibrosis
14%
Endoscopic Sign
14%
Portal Hypertension
14%
Severe Adverse Events
14%
Unmet Needs
14%
Medicine and Dentistry
Fibrosis
100%
Nonalcoholic Fatty Liver
100%
Focused Ion Beam
50%
Randomized Controlled Trial
25%
Liver Fibrosis
25%
Body Mass Index
25%
Body Weight Loss
25%
Gastroesophageal Reflux
25%
Adverse Event
25%
Blood Glucose
25%
Portal Hypertension
25%
Glycated Hemoglobin
25%
Nursing and Health Professions
Nonalcoholic Fatty Liver
100%
Fibrosis
100%
Gastric Balloon
100%
Liver Stiffness
37%
Adverse Event
12%
Liver Fibrosis
12%
Waist Circumference
12%
Glycosylated Hemoglobin
12%
Gastroesophageal Reflux
12%
Body Weight Loss
12%
Portal Hypertension
12%
Glucose Blood Level
12%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
100%
Fibrosis
100%
Focused Ion Beam
50%
Adverse Event
25%
Liver Fibrosis
25%
Gastroesophageal Reflux
25%
Randomized Controlled Trial
25%
Glycosylated Hemoglobin
25%
Portal Hypertension
25%